Managing Physicians, Managing Prescriptions
There was a time when managed care tried to control drug spending through strategies that compromised physician prerogative. But growing consumerism and the healthy US economy has led to questioning of managed care practices. New physician-driven organizations are looking at drug costs as part of a broader disease management agenda, while PBMs are taking a more doctor-friendly approach.
You may also be interested in...
American Injectables plans to build up its US-based manufacturing after securing a commitment for $10m of ‘Series A’ financing from New Rhein Healthcare Investors, which it will use to scale up production and launch several generic parenteral products.
A draft EU guideline explains how disease registries can be used to supplement evidence in the pre-authorization phase and provide infrastructure for post-authorization evidence generation.
Drug companies have their last chance to negotiate which documents and information Italy’s regulator, AIFA, will be entitled to request of them when they submit pricing and reimbursement applications.